An Evaluation Of Corcept Therapeutics Inc (NASDAQ: CORT) Prospects

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Earlier, Yahoo Finance discussed this stock as it revealed Corcept Therapeutics Announces Fourth Quarter and Full-Year 2023 Audited Financial Results and Provides Corporate Update.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

CORT belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Corcept Therapeutics Inc is $2.51B. A total of 0.58 million shares were traded on the day, compared to an average of 1.61M shares.

In the most recent transaction, Swisher Daniel N JR sold 2,200 shares of CORT for 23.59 per share on Mar 01 ’24. After the transaction, the Director now owns 0 company shares. In a previous transaction on Feb 16 ’24, Maduck Sean sold 27,068 shares at 25.97 per share. CORT shares that the insider owns now total 74,455.

Among the insiders who sold shares, Lyon Joseph Douglas disposed of 1,000 shares on Feb 16 ’24 at a per-share price of $26.00. This resulted in the Chief Accounting Officer holding 6,774 shares of CORT after the transaction. In another insider transaction, Maduck Sean sold 4,760 shares at $25.00 per share on Feb 15 ’24. Company shares held by the insider now total 74,455.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, CORT has a high of $34.28 and a low of $20.45.

As of this writing, CORT has an earnings estimate of $0.23 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of $0.29 per share and a lower estimate of $0.19. The company reported an EPS of $0.28 in the last quarter, which was 27.30% higher than expectations of $0.22.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. CORT’s latest balance sheet shows that the firm has $223.53M in Cash & Short Term Investments as of fiscal 2021. There were $526.00k in debt and $47.54M in liabilities at the time. Its Book Value Per Share was $4.90, while its Total Shareholder’s Equity was $375.81M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CORT is Buy with a score of 5.00.

Most Popular

Related Posts